CAS 201216-37-7

Lyso-PAF C-16-d4

CAS: 201216-37-7

Lyso-PAF C-16-d4 is an analog of lysophosphatidic acid, a lipid mediator that plays a role in cancer and other diseases. It has been shown to inhibit the activity of kinases, which are enzymes involved in cell signaling pathways that regulate cell growth and division. This inhibition leads to apoptosis or programmed cell death in cancer cells. Lyso-PAF C-16-d4 has been studied for its potential as an anticancer agent and has shown promising results in Chinese hamster ovary cells and human urine tumor cells. It also acts as a protein kinase inhibitor, which may contribute to its anticancer properties. Additionally, Lyso-PAF C-16-d4 has been investigated for its potential use in Alzheimer's disease treatment due to its similarity to donepezil, a drug used to treat cognitive impairment in patients with Alzheimer's disease.

Formel: C₂₄H₅₃NO₆P

Reinheit: Min. 95%

Molekulargewicht: 482.7 g/mol

Ref: 3D-BIA21637